4503-12-2 Usage
General Description
Carbomethoxyibogamine hydrochloride is a chemical compound that is derived from the psychedelic plant root bark of Tabernanthe iboga. It is a potent hallucinogenic and psychoactive drug that is used for its effects on the central nervous system. The compound is a synthetic derivative of ibogaine, a naturally occurring psychoactive alkaloid, and is often used in research to study its potential therapeutic effects on conditions such as addiction and depression. It is also used in some alternative medicine practices for its purported spiritual and psychological healing properties. However, carbomethoxyibogamine hydrochloride is classified as a Schedule I controlled substance in the United States due to its potential for abuse and lack of approved medical uses.
Check Digit Verification of cas no
The CAS Registry Mumber 4503-12-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,0 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4503-12:
(6*4)+(5*5)+(4*0)+(3*3)+(2*1)+(1*2)=62
62 % 10 = 2
So 4503-12-2 is a valid CAS Registry Number.
4503-12-2Relevant articles and documents
Synthesis of (-)-pseudotabersonine, (-)-pseudovincadifformine, and (+)-coronaridine enabled by photoredox catalysis in flow
Beatty, Joel W.,Stephenson, Corey R. J.
, p. 10270 - 10273 (2014/08/05)
Natural product modification with photoredox catalysis allows for mild, chemoselective access to a wide array of related structures in complex areas of chemical space, providing the possibility for novel structural motifs as well as useful quantities of less abundant congeners. While amine additives have been used extensively as stoichiometric electron donors for photocatalysis, the controlled modification of amine substrates through single-electron oxidation is ideal for the synthesis and modification of alkaloids. Here, we report the conversion of the amine (+)-catharanthine into the natural products (-)-pseudotabersonine, (-)-pseudovincadifformine, and (+)-coronaridine utilizing visible light photoredox catalysis.
